155 related articles for article (PubMed ID: 38201445)
1. Is Metastatic Staging Needed for All Patients with Synchronous Bilateral Breast Cancers?
Lim GH; Hoo JX; Shin YC; Choo RZT; Wong FY; Allen JC
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201445
[TBL] [Abstract][Full Text] [Related]
2. Determining the Need for Metastatic Staging in Patients with Bilateral Breast Cancers.
Alcantara VS; Chan SMZ; Wong FY; Allen JC; Lim GH
Curr Oncol; 2024 Apr; 31(4):1936-1946. PubMed ID: 38668048
[No Abstract] [Full Text] [Related]
3. Breast Cancer Skip Metastases: Frequency, Associated Tumor Characteristics, and Role of Staging Nodal Ultrasound in Detection.
Chung HL; Sun J; Leung JWT
AJR Am J Roentgenol; 2021 Oct; 217(4):835-844. PubMed ID: 32997506
[No Abstract] [Full Text] [Related]
4. [Clinicopathological features and prognosis of synchronous bilateral breast cancers].
Niu YR; Wu HW; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):435-440. PubMed ID: 32392926
[No Abstract] [Full Text] [Related]
5. Need for Staging Investigations in Newly Diagnosed Breast Cancer: Establishing Local Guidelines for Radiological Staging in Bahrain.
Alkazaz AA; Ali NF; Salman AZ; Almahari SA; Altaei TH; Albati WZ; Habib HM; Alsadoon AA; Almawlani NA; Alkhabbaz FA; Eid R; Abdulla HA
Eur J Breast Health; 2024 Apr; 20(2):136-140. PubMed ID: 38571694
[TBL] [Abstract][Full Text] [Related]
6. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
7. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
[TBL] [Abstract][Full Text] [Related]
8. Bilateral synchronous breast cancer and HER-2/neu overexpression.
Safal M; Lower EE; Hasselgren PO; Hungness ES; Gazder P; Aron B; Shaughnessy EA; Yassin R
Breast Cancer Res Treat; 2002 Apr; 72(3):195-201. PubMed ID: 12058961
[TBL] [Abstract][Full Text] [Related]
9. Axillary Nodal Metastases in Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma: Comparison of Node Detection and Morphology by Ultrasound.
Chung HL; Tso HH; Middleton LP; Sun J; Leung JWT
AJR Am J Roentgenol; 2022 Jan; 218(1):33-41. PubMed ID: 34319162
[No Abstract] [Full Text] [Related]
10. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
11. Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer.
Karsten M; Stempel M; Radosa J; Patil S; King TA
Ann Surg Oncol; 2016 Feb; 23(2):471-6. PubMed ID: 26340863
[TBL] [Abstract][Full Text] [Related]
12. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.
Taneja S; Jena A; Goel R; Sarin R; Kaul S
Eur J Radiol; 2014 Dec; 83(12):2231-2239. PubMed ID: 25282709
[TBL] [Abstract][Full Text] [Related]
14. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.
Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349
[TBL] [Abstract][Full Text] [Related]
15. Performance of breast magnetic resonance imaging in axillary nodal staging in newly diagnosed breast cancer patients.
Chayakulkheeree J; Pungrassami D; Prueksadee J
Pol J Radiol; 2019; 84():e413-e418. PubMed ID: 31969959
[TBL] [Abstract][Full Text] [Related]
16. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
Ulaner GA; Castillo R; Goldman DA; Wills J; Riedl CC; Pinker-Domenig K; Jochelson MS; Gönen M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1937-44. PubMed ID: 27129866
[TBL] [Abstract][Full Text] [Related]
17. Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer.
Chen HR; Wu YT; Yu QB; Yang YY; Wei YX; Li HY; Wu KN; Kong LQ
World J Surg Oncol; 2017 Oct; 15(1):189. PubMed ID: 29052527
[TBL] [Abstract][Full Text] [Related]
18. Discordance and clinical significance of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis.
Yao ZX; Lu LJ; Wang RJ; Jin LB; Liu SC; Li HY; Ren GS; Wu KN; Wang DL; Kong LQ
Med Oncol; 2014 Jan; 31(1):798. PubMed ID: 24307349
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Axillary Ultrasound versus Sentinel Lymph Node Biopsy in Patients with Early Breast Cancer.
Rukanskienė D; Veikutis V; Jonaitienė E; Basevičiūtė M; Kunigiškis D; Paukštaitienė R; Čepulienė D; Poškienė L; Boguševičius A
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32183080
[No Abstract] [Full Text] [Related]
20.
Ulaner GA; Juarez J; Riedl CC; Goldman DA
J Nucl Med; 2019 Apr; 60(4):472-477. PubMed ID: 30237211
[No Abstract] [Full Text] [Related]
[Next] [New Search]
